Is precision surgery applicable to colorectal liver metastases? A systematic review and meta-analysis of studies that investigate the association of surgical technique with outcomes in the context of distinct tumor biology Review


Authors: Pikoulis, E.; Papaconstantinou, D.; Pikouli, A.; Pararas, N.; Buettner, S.; Wang, J.; Stasinos, G.; Belias, M.; Dellaportas, D.; Pozios, I.; Antoniou, E.; Beyer, K.; Kreis, M. E.; Pawlik, T. M.; Margonis, G. A.
Review Title: Is precision surgery applicable to colorectal liver metastases? A systematic review and meta-analysis of studies that investigate the association of surgical technique with outcomes in the context of distinct tumor biology
Abstract: Background: Although some data suggest that patients with mutRAS colorectal liver metastases (CRLM) may benefit from anatomic hepatectomy, this topic remains controversial. We performed a systematic review and meta-analysis to determine whether RAS mutation status was associated with prognosis relative to surgical technique [anatomic resection (AR) vs. nonanatomic resection (NAR)] among patients with CRLM. Patients and Methods: A systematic review and meta-analysis of studies were performed to investigate the association of AR versus NAR with overall and liver-specific disease-free survival (DFS and liver-specific DFS, respectively) in the context of RAS mutation status. Results: Overall, 2018 patients (831 mutRAS vs. 1187 wtRAS) were included from five eligible studies. AR was associated with a 40% improvement in liver-specific DFS [hazard ratio (HR) = 0.6, 95% confidence interval (CI) 0.44–0.81, p = 0.01] and a 28% improvement in overall DFS (HR = 0.72, 95% CI 0.54–0.95, p = 0.02) among patients with mutRAS tumors; in contrast, AR was not associated with any improvement in liver-specific DFS or overall DFS among wtRAS patients. These differences may have been mediated by the 40% decreased incidence in R1 resection among patients with mutRAS tumors who underwent AR versus NAR [relative risk (RR): 0.6, 95% CI 0.40–0.91, p = 0.02]. In contrast, the probability of an R1 resection was not decreased among wtRAS patients who underwent AR versus NAR (RR: 0.93, 95% CI 0.69–1.25, p = 0.62). Conclusions: The data suggest that precision surgery may be relevant to CRLM. Specifically, rather than a parenchymal sparing dogma for all patients, AR may have a role in individuals with mutRAS tumors. © Society of Surgical Oncology 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Keywords: controlled study; treatment outcome; cancer surgery; retrospective studies; overall survival; review; liver neoplasms; disease free survival; follow up; biology; tumor volume; recurrence; pathology; retrospective study; risk factor; colorectal neoplasms; systematic review; colorectal tumor; liver tumor; hepatectomy; meta analysis; surgical margin; propensity score; cancer prognosis; colorectal liver metastasis; humans; human; male; female; ras mutation; anatomic; precision surgery
Journal Title: Annals of Surgical Oncology
Volume: 31
Issue: 3
ISSN: 1068-9265
Publisher: Springer  
Date Published: 2024-03-01
Start Page: 1823
End Page: 1832
Language: English
DOI: 10.1245/s10434-023-14774-9
PUBMED: 38155339
PROVIDER: scopus
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in PubMed and PDF -- Corresponding author is MSK authors: G. A. Margonis -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors